1,144 results on '"Ben-Shoshan, Moshe"'
Search Results
152. Anaphylaxis Management by Location: data from the Cross-Canada Anaphylaxis Registry (C-CARE)
153. Long-term adherence and risk of allergic reactions in children who attained milk oral immunotherapy maintenance
154. Impact of COVID-19 Restrictions on Anaphylaxis Presentations to the Emergency Department
155. Safety of Tree Nut Oral Immunotherapy in Clinical Practice
156. Clinical Characteristics, Management and Triggers of Mastocytosis in a Cohort of 39 Patients
157. Bridging knowledge gaps in pediatric urticaria through a video-based educational tool
158. Ligelizumab for adolescent patients with CSU: first results from a dedicated Phase 2b study
159. Comorbidities, Triggers, Management, and Rate of Resolution of Cholinergic Urticaria in 18 Pediatric Patients
160. Safety of Modified Sesame Desensitization Protocols in Children in Real-World Clinical Practice
161. Increased prevalence of autoimmune diseases in children with chronic spontaneous urticaria
162. Dupilumab Significantly Reduces Itch and Hives in Patients With Chronic Spontaneous Urticaria: Results From a Phase 3 Trial (LIBERTY-CSU CUPID Study A)
163. Biomarkers associated with chronic spontaneous urticaria severity in 108 children
164. The Clear Benefit of Epinephrine and Antihistamines, and Questionable Role of Corticosteroids in the Management of Anaphylaxis: 10 Years of Data from the Cross-Canada Anaphylaxis Registry (C-CARE)
165. Bridging knowledge gaps in paediatric chronic urticaria through a video-based educational tool.
166. Short dosing intervals during oral challenge increase the risk of severe adverse reactions in children with milk allergy
167. A population-based study on peanut, tree nut, fish, shellfish, and sesame allergy prevalence in Canada
168. Solar urticaria in a 1-year-old infant: diagnosis and management
169. Friend or foe? Figuring out the difference between FPIES, IgE-mediated allergy and food intolerance
170. Food-dependent exercise-induced anaphylaxis with negative allergy testing
171. Successful Milk Oral Immunotherapy Promotes Generation of Casein-Specific CD137+ FOXP3+ Regulatory T Cells Detectable in Peripheral Blood
172. Increased prevalence of Autoimmune Diseases in Children with Chronic Spontaneous Urticaria
173. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
174. Anaphylaxis-related knowledge and concerns in Canadian families during the coronavirus disease 2019 pandemic
175. Case of postural urticaria in a 14-year-old girl
176. In response to ‘Differences in the prevalence of positive penicillin allergy test results in children and adults’
177. Management Strategies Of Idiopathic Anaphylaxis In The Emergency Room: Current Perspectives
178. Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series
179. Evaluating morbidity and association with autoimmune thyroiditis of chronic urticaria in children: 1844
180. Beta-lactam-allergy testing appears to be inexpensive
181. Cold-induced urticaria: challenges in diagnosis and management
182. Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis
183. Supplementary Material 1 - Supplemental material for Prominent Role of Type 2 Immunity in Skin Diseases—Beyond Atopic Dermatitis
184. Additional file 1 of Demographic characteristics associated with food allergy in a Nationwide Canadian Study
185. The international EAACI/GA(2)LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
186. Food Allergy: Temporal Trends and Determinants
187. 42011 Dupilumab Improves Urticaria Signs and Symptoms and Quality of Life in Patients With Chronic Spontaneous Urticaria (CSU)
188. 43608 Association of Biomarkers with Treatment and Disease Resolution of Chronic Spontaneous Urticaria in Children
189. Anaphylaxis as a presenting symptom of food allergy in children with no known food allergy
190. Comparing food allergy prevalence in vulnerable and nonvulnerable Canadians
191. Rates of anaphylaxis for the most common food allergies
192. A giant sialolith in a 16-year-old boy presenting to the emergency room
193. Temporal trends in prevalence of food allergy in Canada
194. When and how pediatric anaphylaxis cases reach the emergency department: Findings from the Cross-Canada Anaphylaxis Registry
195. Comparing quality of life in Canadian children with peanut, sesame, and seafood allergy
196. Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of Efficacy and Safety.
197. Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines
198. 11 Is emergency department transfer always required following anaphylaxis and epinephrine use?
199. Definition, aims, and implementation of GA 2 LEN/HAEi Angioedema Centers of Reference and Excellence
200. Definition, aims, and implementation of GA²LEN/HAEi Angioedema Centers of Reference and Excellence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.